Enterprise Therapeutics nets $3.6 mln

UK-based Enterprise Therapeutics Ltd, a drug discovery company focused on respiratory diseases, has secured $3.6 million in Series A funding. The investors were Imperial Innovations and Epidarex Capital.

North AmericaUSBriefs